It is a healthcare private limited company based in Jaipur, Rajasthan, India, established in 2021.
2021 | Jaipur, Rajasthan, India | ActiveGats Biotech Private Limited, a active private limited company, was established on 17 February 2021 in Jaipur, Rajasthan, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U33125RJ2021PTC073529. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Anil Kumar Goyal (Director), Toshit Goyal (Director), Ghanshyam Agarwal (Director). Past directors included Savita Agarwal, Manish Agarwal. It holds ₹5.00 Cr open charges and ₹5.90 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No- 121, Silver Soil Industrial Park Opp, Borosil Factory Anantpura, Jaipur, Rajasthan, 303704.
U33125RJ2021PTC073529
073529
17 February 2021
₹0.10 M
₹0.10 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Gats Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar Goyal | Director | 17 Feb 2021 | Current |
| Toshit Goyal | Director | 17 Feb 2021 | Current |
| Ghanshyam Agarwal | Director | 17 Feb 2021 | Current |
| Manish Agarwal | Director | 02 Feb 2024 | Current |
| Saroj Goyal | Director | 01 Nov 2021 | Current |
| Rajendra Kumar Goyal | Director | 01 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gats Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Gats Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹59,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2025 | Others | ₹5.00 Cr | Open |
| 04 May 2023 | Others | ₹5.90 Cr | Satisfied |
Explore comprehensive loan charge details -
Gats Biotech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gats Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gats Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 04 May 2023 via Charge ID 100712073 with Others was fully satisfied on 18 Mar 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 50.00 M with Charge ID 101067247 was registered on 24 Feb 2025. was completed.
The activity Gats Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Gats Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was documented.
The activity Manish Agarwal was appointed as a Director was appointed as a Director on 02 Feb 2024 & has been associated with this company since 1 year 10 months . was completed.
Progress on A charge with Others of Rs. 59.00 M registered on 04 May 2023 with Charge ID 100712073 was modified on 27 Jan 2024. was documented.
The CIN of Gats Biotech Private Limited is U33125RJ2021PTC073529.
Gats Biotech Private Limited is headquartered at Plot No- 121, Silver Soil Industrial Park Opp, Borosil Factory Anantpura, Jaipur, Rajasthan, 303704.
Gats Biotech Private Limited was incorporated on 17 February 2021.
The current directors of Gats Biotech Private Limited are
The primary industry of Gats Biotech Private Limited is Hospital And Medical Care.
Gats Biotech Private Limited is unlisted.
The authorized capital of Gats Biotech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX